Evidence map›Paper›PMID 30593799›Full record

SynthesisGastroenterology2019

Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.

Candelaria Vergara, Chloe L Thio, Eric Johnson, Alex H Kral, Thomas R O'Brien, James J Goedert, Alessandra Mangia, Valeria Piazzolla, Shruti H Mehta, Gregory D Kirk and 20 more

Abstract readComparative StudyMeta-Analysis
In one paragraph

Synthesis in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  5. Osteocalcin and GPR158: linking bone and brain function.Frontiers in cell and developmental biology · 2025
    Review
  6. Frequencies of anInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Variants ofGenes · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Genomewide Association Studies in Pharmacogenomics.Clinical pharmacology and therapeutics · 2021
    Review
  14. Article
  15. Review
  16. Review
  17. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Article
  18. Article
  19. Article
  20. An immunogenetic view of COVID-19.Genetics and molecular biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 14 institutions in 5 countries.

Candelaria VergaraJohns Hopkins University, School of Medicine, Baltimore, Maryland.
Chloe L ThioJohns Hopkins University, School of Medicine, Baltimore, Maryland.
Eric JohnsonResearch Triangle Institute International, Research Triangle Park, North Carolina; Atlanta, Georgia; San Francisco, California.
Alex H KralResearch Triangle Institute International, Research Triangle Park, North Carolina; Atlanta, Georgia; San Francisco, California.
Thomas R O'BrienDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
James J GoedertLiver Unit Istituto Di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Alessandra MangiaLiver Unit Istituto Di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Valeria PiazzollaLiver Unit Istituto Di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Shruti H MehtaJohns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.
Gregory D KirkJohns Hopkins University, School of Medicine, Baltimore, Maryland; Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.
Arthur Y KimLiver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Georg M LauerLiver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Raymond T ChungLiver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Andrea L CoxJohns Hopkins University, School of Medicine, Baltimore, Maryland.
Marion G PetersDivision of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Francisco, California.
Salim I KhakooUniversity of Southampton, Southampton General Hospital, Southampton, UK.
Laurent AlricDepartment of Internal Medicine and Digestive Diseases, Centre Hospitalier Universitaire Purpan, UMR 152, Institut de Recherche pour le Développement Toulouse 3 University, France.
Matthew E CrampSouth West Liver Unit, Plymouth, UK.
Sharyne M DonfieldRho, Inc, Chapel Hill, North Carolina.
Brian R EdlinState University of New York Downstate College of Medicine, Brooklyn, New York.
Michael P BuschUniversity of California and Vitalant Research Institute, San Francisco, California.
Graeme AlexanderUniversity College London Institute for Liver and Digestive Health, The Royal Free Hospital, London, UK.
Hugo R RosenUniversity of Colorado, Aurora, Colorado.
Edward L MurphyUniversity of California and Vitalant Research Institute, San Francisco, California.
Rachel LatanichJohns Hopkins University, School of Medicine, Baltimore, Maryland.
Genevieve L WojcikDepartment of Genetics, Stanford University School of Medicine, Stanford, California.
Margaret A TaubJohns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.
Ana ValenciaJohns Hopkins University, School of Medicine, Baltimore, Maryland; Universidad Pontificia Bolivariana, Medellin, Colombia.
David L ThomasJohns Hopkins University, School of Medicine, Baltimore, Maryland.
Priya DuggalJohns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: pduggal@jhu.edu.
Johns Hopkins University · USCasa Sollievo della Sofferenza · ITHarvard University · USPacific Research Institute · USRTI International · USInstitut de Recherche pour le Développement · FRNational Institutes of Health · USRho (United States) · USSouthampton General Hospital · GBStanford University · USState University of New York · USThe Royal Free Hospital · GBUniversity of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2M
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4M
MULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4M
Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
CCR NIH HHS HHSN261200800001CNCATS NIH HHS UL1 TR002384NCI NIH HHS HHSN261200800001ENCRR NIH HHS UL1 RR024996NCRR NIH HHS UL1 RR025005NHLBI NIH HHS R01 HL076902NHLBI NIH HHS U01 HL146201NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI035040NIAID NIH HHS U01 AI035041NIAID NIH HHS U01 AI035042NIAID NIH HHS U01 AI035043NIAID NIH HHS U01 AI042590NIAID NIH HHS U01 AI131314NIAID NIH HHS U19 AI066345NIAID NIH HHS U19 AI082630NIAID NIH HHS U19 AI088791NICHD NIH HHS R01 HD041224NICHD NIH HHS U01 HD032632NIDA NIH HHS R01 DA004334NIDA NIH HHS R01 DA012568NIDA NIH HHS R01 DA013324NIDA NIH HHS R01 DA016159NIDA NIH HHS R01 DA021550NIDA NIH HHS R01 DA033541NIDA NIH HHS R37 DA004334NIDA NIH HHS R56 DA004334NIDA NIH HHS U01 DA036297
6 · The paper itself

Abstract

BACKGROUND &

aimsSpontaneous clearance of hepatitis C virus (HCV) occurs in approximately 30% of infected persons and less often in populations of African ancestry. Variants in major histocompatibility complex (MHC) and in interferon lambda genes are associated with spontaneous HCV clearance, but there have been few studies of these variants in persons of African ancestry. We performed a dense multi-ancestry genome-wide association study of spontaneous clearance of HCV, focusing on individuals of African ancestry.

methodsWe performed genotype analyses of 4423 people from 3 ancestry groups: 2201 persons of African ancestry (445 with HCV clearance and 1756 with HCV persistence), 1739 persons of European ancestry (701 with HCV clearance and 1036 with HCV persistence), and 486 multi-ancestry Hispanic persons (173 with HCV clearance and 313 with HCV persistence). Samples were genotyped using Illumina (San Diego, CA) arrays and statistically imputed to the 1000 Genomes Project. For each ancestry group, the association of single-nucleotide polymorphisms with HCV clearance was tested by log-additive analysis, and then a meta-analysis was performed.

resultsIn the meta-analysis, significant associations with HCV clearance were confirmed at the interferon lambda gene locus IFNL4-IFNL3 (19q13.2) (P = 5.99 × 10

conclusionsIn a meta-analysis of data from 3 studies, we found variants in MHC genes, IFNL4-IFNL3, and GPR158 to increase odds of HCV clearance in patients of European and African ancestry. These findings could increase our understanding of immune response to and clearance of HCV infection.

Indexed as

Black or African AmericanBlack PeopleFemaleGenome-Wide Association StudyHepacivirusHepatitis CHispanic or LatinoHost-Pathogen InteractionsHumansInterferon LambdaInterferonsInterleukinsMajor Histocompatibility ComplexMaleReceptors, G-Protein-CoupledRemission, SpontaneousIFNL4 protein, humanInterferon Lambdainterferon-lambda, humanInterferonsInterleukinsReceptors, G-Protein-CoupledCytokineGWASRiskSNP

Identifiers

PMID30593799
PMCPMC6788806
OpenAlexW2906171717

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.